FENNEC PHARMACEUTICALS INC. Gain (Loss) on Disposition of Assets
FENNEC PHARMACEUTICALS INC. (FENC) reported Gain (Loss) on Disposition of Assets of $0 for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-28.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets1 · last filed 2018-03-28
- FENNEC PHARMACEUTICALS INC. gain (loss) on disposition of assets for the quarter ending 2017-12-31 was $0.00.
- FENNEC PHARMACEUTICALS INC. gain (loss) on disposition of assets for the quarter ending 2017-09-30 was $0.00, a 100.00% decline year-over-year.
- FENNEC PHARMACEUTICALS INC. gain (loss) on disposition of assets for the quarter ending 2016-12-31 was $0.00.
- FENNEC PHARMACEUTICALS INC. gain (loss) on disposition of assets for the quarter ending 2016-09-30 was $40.00K.
- FENNEC PHARMACEUTICALS INC. gain (loss) on disposition of assets for fiscal 2017 was $0.00, a 100.00% decline from fiscal 2016.
- FENNEC PHARMACEUTICALS INC. gain (loss) on disposition of assets for fiscal 2016 was $40.00K.
- FENNEC PHARMACEUTICALS INC. gain (loss) on disposition of assets for fiscal 2015 was $0.00.
| Period end | Gain (Loss) on Disposition of Assets 3 month | Gain (Loss) on Disposition of Assets 6 month | Gain (Loss) on Disposition of Assets 9 month | Gain (Loss) on Disposition of Assets 12 month |
|---|---|---|---|---|
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-28 | $0.00 derived: sum of 2 quarters · filed 2018-03-28 | $0.00 10-K · filed 2018-03-28 | |
| 2017-09-30 | $0.00 10-Q · filed 2017-11-13 | $0.00 10-Q · filed 2017-11-13 | ||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-28 | $40.00K derived: sum of 2 quarters · filed 2018-03-28 | $40.00K 10-K · filed 2018-03-28 | |
| 2016-09-30 | $40.00K 10-Q · filed 2017-11-13 | $40.00K 10-Q · filed 2017-11-13 | ||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-29 | $0.00 derived: sum of 2 quarters · filed 2017-03-29 | $0.00 10-K · filed 2017-03-29 | |
| 2015-09-30 | $0.00 10-Q · filed 2016-11-14 | $0.00 10-Q · filed 2016-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |